Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2, a minor label change with no impact on page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe India location entry was updated from Gurgaon, India, 122001 to Gūrgaon, India, 122001.SummaryDifference0.0%

- Check33 days agoChange DetectedThe changes consist of updated metadata timestamps (2026-01-21, 2026-01-20, 2026-01) and a new 'Last Update Posted' entry. The core study content, including eligibility, cohorts, and endpoints, remains unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. There are no visible changes to the study content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedNew locations across the US states, Canadian provinces, and Gurgaon, India were added, and several existing sites were removed.SummaryDifference0.9%

- Check70 days agoChange DetectedThe India location entry for 122001 was updated from Gurgaon to Gūrgaon (with a diacritic) to reflect the revised place name.SummaryDifference0.0%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.